skyhatch1 | 10 years ago | on: How we were building the wrong product
skyhatch1's comments
skyhatch1 | 10 years ago | on: Is group chat making you sweat?
Last year, I met with the EVP of a division at a Fortune 500 company in New York, to discuss a partnership opportunity for our software company.
His direct reports had talked us up to him because we had a highly differentiated offering for a crowded space; one which his company was competing in.
It all went south as soon as the EVP recalled his experience with Slack. "You guys sound like this Slack we tried last month." While our product didn't handle group chat whatsoever, I couldn't convince him otherwise.
According to him, Slack increased the noise in their communications because they "worked on a long-term case/problem basis" and they and "always refer back to conversations", which was difficult to do with constant chatter.
skyhatch1 | 10 years ago | on: The Mystery of When to Stop Antidepressants
Many doctors, especially psychiatrists, use clinically-proven if-then-else type criteria tools created by professional psychiatrist bodies.
As your therapy progresses, depending on how you score with the criteria, the doctor will opt to:
- Taper down and cease medication
- Reduce medication dose and supplement with behavioral therapy
- Stay on the current dose
- Increase dose if your symptoms worsen
skyhatch1 | 10 years ago | on: Why huge gains in drug discovery tech have led to longer drug development times
Governments and insurers are too astute to pay excessively for incremental improvements in mass or lifestyle disease categories. It makes more business sense for Big Pharma to target complex, hard-to-cure diseases that affect a small population set. While the success rate for such molecules is much lower, it's also much harder for payers to apply their usual mass-oriented drug economics to them.
One of the better examples of this is the recent introduction of Hep C "curing" drugs. Sponsors are going uncontested in pricing their molecules up to $84,000 per patient year[1,2].
With 3 million patients in the US alone, that's a TAM of $252 billion per year. For one drug category.
References:
[1] http://hepatitiscresearchandnewsupdates.blogspot.com/2014/03...
[2] http://www.grassley.senate.gov/news/news-releases/senators-s...
skyhatch1 | 10 years ago | on: Kofi Annan on Why It's Time to Legalize Drugs
Nonetheless, the other hand always wants its share. In the case of Australia, harm minimisation has reduced drug-related crimes, but the prevalence of drug use in the general population continues to rise, especially with regard to pills and amphetamines. Blood borne viruses are also on the rise, despite the ubiquity of safe injecting rooms in every major city and availability of "sharps kits" in every retail pharmacy.
Interestingly, the conservative party temporarily swayed from this stance and implemented a "tough on drugs" policy for part of the 90s[1]. It was dubbed to the wider public as a "harm prevention" measure i.e. protecting those yet to experiment with drugs and the wider community that didn't use illicit drugs regularly. There was a significant reduction in every measure: drug use, drug crime and spread of blood-borne viruses. This policy did not cut safe injecting and drug use services, but increased police activity and ephemeral "say no to drugs" cut-through education programs. The policy was reversed in the early 2000s.
[1] https://www.unodc.org/documents/ungass2016/Contributions/Civ...
skyhatch1 | 10 years ago | on: What's so bad about mandatory workplace socializing?
There's a lot of talk about culture - especially in startups. This article challenges the notion of culture, and could force many to think about and clarify their position. I have experienced what the author has - being the odd one out in a homogeneous workgroup, having to force myself to fit in socially just to get some work done!
skyhatch1 | 10 years ago | on: Break Up the Insulin Racket
However, it seems like there are no visible protocols in place to control use in non-emergency situations like with the patient mentioned in the NYTimes article. That's certainly risky for poorer diabetics who don't necessarily know better, or are desperate enough financially to risk the long-term consequences.
skyhatch1 | 10 years ago | on: Break Up the Insulin Racket
I'm guessing a no carb diet could also imply high protein, to replace the carbohydrate calories. Too much protein (>20% of calories) is bad for Type I diabetics leading to a state known as microalbuminuria. In layman's terms: increased stress on your kidneys. More on this at: http://journal.diabetes.org/diabetesspectrum/00v13n3/pg132.h...
In summary, almost every (if not every) diabetes publication & specialist advises heavily against low/no carb diets, instead recommending a balanced diet.
skyhatch1 | 10 years ago | on: An Open Letter to My CEO
However, the post risks polarizing readers, most of whom could start to see or confirm that managers don't care about the plight of their lowest rung. At my work, our lowest level employees get paid ~$23/hour, but even at that level, a few still complain about their wages being too low to live on. Managers are perhaps myopic in thinking about living wages, but they don't have much choice.
Companies like Yelp are coming of age, and that means they need to turn profits, not just grow. Most such businesses have strict wage budgets, usually a % of revenue, to control operating costs. In this case, if Yelp's CEO capitulates and increases wages, his team will have to hire less people than before.
Perhaps once again, a lose-lose situation. The business loses servicing power and less people get the opportunity to work towards their dream of working in media.
skyhatch1 | 10 years ago | on: An Open Letter to My CEO
At the end of the day, the author - like anybody living in the free world - has the choice to pack and move to a more accommodating work/home situation.
skyhatch1 | 10 years ago | on: How High-Flying Zenefits Fell to Earth
This would not have happened if the person selling you the insurance was under a legal (read: license) obligation to provide you the most appropriate insurance.
skyhatch1 | 10 years ago | on: Douglas Rushkoff: I’m thinking it may be good to be off social media altogether
skyhatch1 | 10 years ago | on: Douglas Rushkoff: I’m thinking it may be good to be off social media altogether
skyhatch1 | 10 years ago | on: Kubrick's ‘Barry Lyndon,’ a masterclass in bringing a filmmaker's vision to life
skyhatch1 | 10 years ago | on: Wired for gaming: Brain differences in compulsive video game players
skyhatch1 | 10 years ago | on: 100 Days of Swift
skyhatch1 | 10 years ago | on: How Lufthansa Cares for Passengers' Medical Needs (2014)
With a conservative 40% of urgent cases being treatable under the Doctors on Board program, that's a $2.16m saving.
Cost of such a program is next to negligible - airlines spend hundreds of $ per flyer per year marketing in various ways to frequent flyers. A €50 discount voucher per flyer certainly won't break the bank.
skyhatch1 | 10 years ago | on: What it’s like to house-hunt in Silicon Valley, the nation’s priciest market
skyhatch1 | 10 years ago | on: If You Build It, They Will Complain
But now it seems that we've automated pretty much everything we could, so where to now for the technically minded lazy opportunist?
skyhatch1 | 10 years ago | on: Dear Architects: Sound Matters
We developed what we thought and what our potential customers claimed was a solution to an unmitigated problem in a very sensitive financial process. We followed startup advice and made it clear that we would charge for the solution. Fast forward a few months: usage dropped from supercharged to minimal then to nothing. Most of the customers we worked so hard to acquire went back to their old ways. When we did followup calls, their newer recruits were none the wiser that we even built something specifically for them. Clearly, the problem wasn't that important in the grand scheme of things.